Research Triangle Park, NC and Basel – Novartis has strengthened its vaccines pipeline through an exclusive agreement to license AlphaVax’ investigational Cytomegalovirus (CMV) vaccine program. This CMV agreement adds to Novartis’ promising early stage pipeline of novel vaccines, which focuses on significant unmet needs for the prevention of fatal diseases such as meningococcal infections and other hospital and community acquired infections. (more…)

DURHAM, NC– In the midst of a volatile financial market that has many investors sitting on their hands and clinging to their cash, Pappas Ventures has raised $96 million toward a projected $200 million venture fund. (more…)

Atlanta, GA— Southeast BIO (SEBIO) announced four winners of the Second Annual SEBIO Awards in a ceremony held at its Tenth Anniversary Investor Forum in Palm Beach, FL on December 5th. The awards honored companies in the following categories: Southeast (SE) Deal of the Year: Initial Funding; SE Deal of the Year: Venture Capital Transaction and SE Deal of the Year: Strategic Transaction. In addition, the organization awarded its SE Leadership Award to an individual or organization that made a notable contribution to the growth of the life sciences industry in the region over the last year. The winners were ViewRay, Inc., Biolex, Inc., Serenex, Inc., and Rebecca Kaufman of King & Spalding, respectively. (more…)

Atlanta, GA – Southeast BIO (SEBIO), a regional nonprofit organization dedicated to fostering the growth of the Southeast’s life sciences industry, has announced the winner of its second annual BIO/Plan Competition, a year long business creation competition. The winner is Cerene Biomedics, Inc. (Durham, NC). Cerene Biomedics will take home the $100,000.00 (non-dilutive) BIO/Plan 1st prize. (more…)

Atlanta, GA– More than 400 people attended the Tenth Anniversary Southeastern BIO Investor Forum on December 4-5th in Palm Beach, Florida. The Forum is the Southeast’s premier life sciences venture capital forum. (more…)